Research progress and perspectives of non-coding RNAs in primary biliary cholangitis: from mechanisms to therapeutics
Authors:
Open Access
- 4 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1611640
Abstract
Primary biliary cholangitis (PBC), an autoimmune-mediated cholestatic liver disease with a female predominance, remains enigmatic in its pathogenesis despite advances in understanding immune dysregulation, bile acid dyshomeostasis, inflammatory cascades, gut-liver axis crosstalk, and sex-biased mechanisms. Although ursodeoxycholic acid is widely recognized as the first-line therapy, its variable efficacy underscores the need for novel biomarkers and targeted therapies. Non-coding RNAs (ncRNAs), though not encoding proteins, have emerged as promising candidates due to their pivotal regulatory roles in autoimmune processes. This review systematically delineates the interplay between ncRNAs (miRNAs, lncRNAs, circRNAs) and key PBC mechanisms, evaluates their diagnostic and therapeutic potential, and proposes future research frameworks to bridge molecular insights with clinical translation.Keywords
This publication has 110 references indexed in Scilit:
- MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activationHepatology, 2017
- Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progressionHepatology, 2017
- Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cellsRedox Biology, 2017
- miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitisJournal of Hepatology, 2017
- H19 promotes cholestatic liver fibrosis by preventing ZEB1‐mediated inhibition of epithelial cell adhesion moleculeHepatology, 2017
- The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout miceHepatology, 2017
- Identification of microRNA profiles associated with refractory primary biliary cirrhosisMolecular Medicine Reports, 2016
- Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506Journal of Biological Chemistry, 2015
- Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell linesNucleic Acids Research, 2014
- Up-regulation of microRNA 506 leads to decreased Cl−/HCO3 − anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosisHepatology, 2012